IFN-gamma and Fas/FasL are required for the antitumor and antiangiogenic effects of IL-12/pulse IL-2 therapy.
暂无分享,去创建一个
J. Wigginton | T. Back | R. Wiltrout | J. Park | L. Geiselhart | K. Komschlies | J. Subleski | T. Wiltrout | E. Gruys | K. Nagashima | J. Park